Organogenesis Holding (NASDAQ: ORGO) reported Q4 EPS of $0.24, $0.02 better than the analyst estimate of $0.22. Revenue for the quarter came in at $225.1 million versus the consensus estimate of $172.67 million.

GUIDANCE:

Organogenesis Holding sees FY2026 revenue of $350-420 million, versus the consensus of $543.4 million.

For earnings history and earnings-related data on Organogenesis Holding (ORGO) click here.